跳至主要内容
临床试验/NCT00396136
NCT00396136已完成4 期

Corox OTW Steroid LV Lead Monitoring

Biotronik, Inc.2 个研究点 分布在 1 个国家目标入组 221 人开始时间: 2006年10月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
221
试验地点
2
主要终点
Long-term Effectiveness of the COROX Over-the-wire (OTW) Steroid in Providing Biventricular Pacing

研究概览

简要总结

The objective of this post approval registry is to confirm the long-term safety and effectiveness of the Corox Over-the-wire (OTW) Steroid Left Ventricular (LV) lead as used in conjunction with a BIOTRONK cardiac resynchronization therapy defibrillator (CRT-D). The Corox OTW Steroid LV Lead is capable of providing permanent pacing therapy to the left ventricle in a CRT-D system. The following are the specific objectives to be evaluated during this post-approval registry:

  • Long-term effectiveness of the COROX OTW Steroid in providing biventricular pacing
  • Safety of the COROX OTW Steroid LV pacing lead

详细描述

This post approval registry enrolled 221 patients from 34 centers. The collection of registry data continued for three years for each enrolled subject. Potential patients were screened by the enrolling physician according to the detailed inclusion and exclusion criteria below.

The specific required visits for this registry are: Enrollment, Three-month, Six month, One-year, Routine Follow-Ups (every subsequent 6 months), Interim follow-ups for Corox OTW Steroid LV lead related visits, and Out of Service visit. Data will be collected at each patient follow-up. The programmed pacing parameters, LV pacing impedance, and LV pacing threshold measurement at 0.5ms pulse width will be obtained. The programming parameters will be set to best suit each patient. If adequate system function, including effective CRT, cannot be obtained, the patient should not be selected for the registry.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Successfully implanted BIOTRONIK CRT-D system, including the Corox OTW Steroid LV Lead, from 1-30 days prior to enrollment
  • Able to understand the nature of the registry and give informed consent
  • Available for follow-up visits on a regular basis at the investigational site
  • Age greater than or equal to 18 years

排除标准

  • Enrolled in another cardiovascular or pharmacological clinical investigation
  • Planned cardiac surgical procedures or interventional measures within the next 6 months
  • Expected to receive a heart transplant within 6 months
  • Life expectancy less than 6 months
  • Presence of another life-threatening, underlying illness separate from their cardiac disorder
  • Pregnancy

结局指标

主要结局

Long-term Effectiveness of the COROX Over-the-wire (OTW) Steroid in Providing Biventricular Pacing

时间窗: All follow-ups for 3 years post implant

Evaluate threshold voltage of the COROX OTW Unipolar Lead.

Safety of the COROX OTW Steroid LV Pacing Lead

时间窗: 3 years post implant

Number of participants with LV lead related adverse events requiring additional invasive intervention to resolve.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验